Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.43
+1.32 (5.97%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -353 | -283 | -307 | -267 | 53 | |
| Depreciation & Amortization | 10 | 10 | 8 | 6 | 4 | |
| Asset Writedown & Restructuring Costs | - | 20 | - | - | - | |
| Loss (Gain) From Sale of Investments | -13 | -25 | -19 | - | 5 | |
| Stock-Based Compensation | 60 | 76 | 73 | 65 | 55 | |
| Other Operating Activities | 8 | 10 | 10 | 11 | 3 | |
| Change in Accounts Receivable | 9 | 28 | 15 | 704 | -17 | |
| Change in Accounts Payable | 24 | 3 | -1 | 8 | -5 | |
| Change in Unearned Revenue | -240 | -56 | -68 | -112 | -368 | |
| Change in Other Net Operating Assets | 13 | 47 | -17 | 23 | 14 | |
| Operating Cash Flow | -482 | -170 | -306 | 438 | -256 | |
| Capital Expenditures | -2 | -6 | -24 | -6 | -26 | |
| Investment in Securities | 68 | -78 | 218 | -404 | 22 | |
| Other Investing Activities | - | - | - | -3 | - | |
| Investing Cash Flow | 66 | -84 | 194 | -413 | -4 | |
| Long-Term Debt Issued | 49 | 47 | - | - | - | |
| Net Debt Issued (Repaid) | 49 | 47 | - | - | - | |
| Issuance of Common Stock | 439 | 237 | 33 | 23 | 232 | |
| Repurchase of Common Stock | - | -7 | - | - | - | |
| Other Financing Activities | - | - | - | 10 | 5 | |
| Financing Cash Flow | 488 | 277 | 33 | 33 | 237 | |
| Net Cash Flow | 72 | 23 | -79 | 58 | -23 | |
| Free Cash Flow | -484 | -176 | -330 | 432 | -282 | |
| Free Cash Flow Margin | -195.95% | -68.22% | -282.05% | 385.71% | -73.63% | |
| Free Cash Flow Per Share | -4.51 | -1.95 | -4.46 | 6.00 | -3.81 | |
| Cash Interest Paid | 7 | 1 | - | - | - | |
| Cash Income Tax Paid | - | - | 5 | 3 | - | |
| Levered Free Cash Flow | -162.25 | -41.25 | -187.75 | 617.75 | -644.75 | |
| Unlevered Free Cash Flow | -157.25 | -38.75 | -186.5 | 619 | -644.75 | |
| Change in Working Capital | -194 | 22 | -71 | 623 | -376 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.